Novation, a leading healthcare supply contracting company, is now offering SurgiLance® safety lancets and babyLance™ infant heel incision devices to the more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC) and nearly 15,000 members of Provista, LLC.
“Our relationship with Novation dates back to 2005, and we are incredibly pleased that Novation continues to recognize the value of our medical products,” said MediPurpose Vice President Mark Stoppenbach. “Novation’
Since its launch in 1999, SurgiLance® safety lancets have become one of the world’s most popular needlestick solutions.
Introduced in July 2010 and specially designed for newborn caregivers, babyLance™ infant heel incision devices are MediPurpose’
Founded in 1998, Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances and nearly 15,000 members of Provista, LLC.
Novation offers its customers contract development and management, supply-chain data and measurement, and industry knowledge and advocacy.
Based in Irving, Texas, Novation develops and manages competitive contracts with more than 500 suppliers. VHA, UHC and Provista members used Novation contracts to purchased nearly $35.7 billion in 2008.
For more information on Novation, visit http://www.novationco.com.
# # #
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular SurgiLance® safety lancet, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and medical product distributors.
MediPurpose's Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.
For more information about MediPurpose’